From October 9-16, 2024, China Structural Week 2024 was grandly held. TaurusNXT® 

❖ New Third-Generation Dry Valve TAVR System Registration Study: One-Year Clinical Follow-up Results Released 

Professor Zhou Daxin from Zhongshan Hospital affiliated with Fudan University announced the oneyear clinical follow-up results of the registration study for the new third-generation dry valve TAVR system —TaurusNXT® Transcatheter Aortic Valve System. The registration study presented at this conference is a prospective, multicenter, single-arm target value study that included 150 patients from 17 centers, with all 150 patients completing one-month postoperative follow-up and 117 completing oneyear follow-up (78%). The enrolled patients had a high proportion of severe and extremely severe calcification, with the calcification score of the bicuspid group significantly higher than that of the tricuspid group. The procedural operation was challenging, and the proportion of bicuspid valves was close to 50%, which is consistent with the realworld distribution, and its results can provide strong guidance for the real-world application of TaurusNXT®.